Yidu Tech Past Earnings Performance
Past criteria checks 0/6
Yidu Tech has been growing earnings at an average annual rate of 31.7%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 9.5% per year.
Key information
31.7%
Earnings growth rate
47.1%
EPS growth rate
| Healthcare Services Industry Growth | 22.3% |
| Revenue growth rate | 9.5% |
| Return on equity | -5.4% |
| Net Margin | -24.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Yidu Tech Inc. (HKG:2158) Analysts Are Reducing Their Forecasts For This Year
Jul 02
Is Yidu Tech Inc. (HKG:2158) Potentially Undervalued?
Jun 19Companies Like Yidu Tech (HKG:2158) Are In A Position To Invest In Growth
Apr 12We're Interested To See How Yidu Tech (HKG:2158) Uses Its Cash Hoard To Grow
Oct 11It's Down 28% But Yidu Tech Inc. (HKG:2158) Could Be Riskier Than It Looks
Aug 16News Flash: 6 Analysts Think Yidu Tech Inc. (HKG:2158) Earnings Are Under Threat
Jul 05We Think Yidu Tech (HKG:2158) Can Afford To Drive Business Growth
May 04We Think Yidu Tech (HKG:2158) Can Afford To Drive Business Growth
Jan 27Yidu Tech Inc. (HKG:2158) Analysts Are More Bearish Than They Used To Be
Dec 01We're Interested To See How Yidu Tech (HKG:2158) Uses Its Cash Hoard To Grow
Sep 16Yidu Tech Inc.'s (HKG:2158) Intrinsic Value Is Potentially 54% Above Its Share Price
Nov 18Here's Why We're Not At All Concerned With Yidu Tech's (HKG:2158) Cash Burn Situation
Oct 14Calculating The Intrinsic Value Of Yidu Tech Inc. (HKG:2158)
Aug 04Revenue & Expenses Breakdown
How Yidu Tech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 807 | -195 | 485 | 233 |
| 31 Dec 23 | 747 | -273 | 494 | 249 |
| 30 Sep 23 | 687 | -350 | 503 | 264 |
| 30 Jun 23 | 746 | -489 | 534 | 303 |
| 31 Mar 23 | 805 | -628 | 565 | 343 |
| 31 Dec 22 | 1,007 | -652 | 597 | 351 |
| 30 Sep 22 | 1,210 | -675 | 629 | 359 |
| 30 Jun 22 | 1,223 | -719 | 714 | 364 |
| 31 Mar 22 | 1,237 | -762 | 798 | 369 |
| 31 Dec 21 | 1,148 | -1,855 | 741 | 342 |
| 30 Sep 21 | 1,060 | -2,948 | 683 | 315 |
| 30 Jun 21 | 948 | -3,415 | 628 | 270 |
| 31 Mar 21 | 867 | -3,700 | 515 | 222 |
| 30 Jun 20 | 704 | -1,349 | 481 | 241 |
| 31 Mar 20 | 558 | -1,510 | 494 | 264 |
| 31 Mar 19 | 102 | -934 | 193 | 258 |
| 31 Mar 18 | 23 | -978 | 93 | 154 |
Quality Earnings: 2158 is currently unprofitable.
Growing Profit Margin: 2158 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2158 is unprofitable, but has reduced losses over the past 5 years at a rate of 31.7% per year.
Accelerating Growth: Unable to compare 2158's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2158 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.2%).
Return on Equity
High ROE: 2158 has a negative Return on Equity (-5.41%), as it is currently unprofitable.